Molecular genotyping in medullary thyroid cancer

被引：2
|
作者：
Newbold, Kate [1 ,2 ]
机构：
[1] Royal Marsden NHS Fdn Trust Hosp, London, England
[2] Royal Marsden NHS Fdn Trust Hosp, Consultant Clin Oncologist, Fulham Rd, London SW3 6JJ, England
来源：
CURRENT OPINION IN ONCOLOGY | 2023年 / 35卷 / 01期
关键词：
medullary thyroid cancer; rearranged during transfection; ACQUIRED-RESISTANCE; RET PROTOONCOGENE; RAS MUTATIONS; CARCINOMA; ACTIVATION; SELPERCATINIB; CABOZANTINIB;
D O I：
10.1097/CCO.0000000000000915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose of reviewThere has been a significant advance in our understanding of the molecular biology of medullary thyroid cancer (MTC) alongside progress in the development of targeted therapies including multikinase and specific rearranged during transfection inhibitors.Recent findingsThis review will examine the latest data investigating the impact of the genomics of MTC on the prediction of the natural history of an individual's disease and the determination, selection and timing of treatment interventions.Recent advances in genotyping in MTC and the development of targeted therapies have impacted on the clinical management of both sporadic and hereditary MTC.
引用
收藏
页码：10 / 14
页数：5
相关论文
共 50 条
  • [41] Thyroid Cancer Genetics: Multiple Endocrine Neoplasia Type 2, Non-Medullary Familial Thyroid Cancer, and Familial Syndromes Associated with Thyroid Cancer
    Richards, Melanie L.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 18 (01) : 39 - +
  • [42] Surgical management of sporadic medullary thyroid cancer
    Noullet, S.
    Tresallet, C.
    Godiris-Petit, G.
    Hoang, C.
    Leenhardt, L.
    Menegaux, F.
    JOURNAL OF VISCERAL SURGERY, 2011, 148 (04) : E244 - E249
  • [43] Medullary thyroid cancer presenting with airway obstruction
    Shah, P.
    Reddy, C.
    Lawrence, R.
    Sudarshan, P.
    Wilne, S.
    Daniel, M.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY EXTRA, 2016, 14 : 1 - 3
  • [44] Medical Management of Metastatic Medullary Thyroid Cancer
    Maxwell, Jessica E.
    Sherman, Scott K.
    O'Dorisio, Thomas M.
    Howe, James R.
    CANCER, 2014, 120 (21) : 3287 - 3301
  • [45] Initial surgical management of medullary thyroid cancer
    Coan, Kathryn E.
    Wang, Tracy S.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2016, 3 (03) : 259 - 266
  • [46] Advances in the management of hereditary medullary thyroid cancer
    Machens, A
    Ukkat, J
    Brauckhoff, M
    Gimm, O
    Dralle, H
    JOURNAL OF INTERNAL MEDICINE, 2005, 257 (01) : 50 - 59
  • [47] State of the art and future directions in the systemic treatment of medullary thyroid cancer
    Jager, Eline C.
    Broekman, K. Esther
    Kruijff, Schelto
    Links, Thera P.
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (01) : 1 - 8
  • [48] Influence of lymph node metastases on survival in pediatric medullary thyroid cancer
    Raval, Mehul V.
    Sturgeon, Cord
    Bentrem, David J.
    Elaraj, Dina M.
    Stewart, Andrew K.
    Winchester, David J.
    Ko, Clifford Y.
    Reynolds, Marleta
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (10) : 1947 - 1954
  • [49] Anti-tumor activity of motesanib in a medullary thyroid cancer model
    Coxon, A.
    Bready, J.
    Kaufman, S.
    Estrada, J.
    Osgood, T.
    Canon, J.
    Wang, L.
    Radinsky, R.
    Kendall, R.
    Hughes, P.
    Polverino, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (02) : 181 - 190
  • [50] Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
    Madhavi Nagilla
    Rebecca L. Brown
    Ezra E. W. Cohen
    Advances in Therapy, 2012, 29 : 925 - 934
12345